Obesity care in India is evolving—no longer just diets & surgery, it’s all about multi-specialty approach

Further, as many as 7 crore adults in India were categorised as obese in 2022, according…

UK investigates weight-loss jab risks after many hospitalised with pancreatitis | Today News

A new study by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England…

In battle for Indian anti-obesity market, Eli Lilly’s pre-filled pen on one side, Novo Nordisk’s on other

New Delhi: Eli Lilly India, makers of the obesity drug Mounjaro, said Thursday that they have…

Access to obesity management not available to most Indian patients: World Heart Federation report | Today News

Mumbai: Obesity in India has risen tremendously in the last 35 years, in tandem with rising…

Mounjaro vs Wegovy: Guess which obesity drug outperformed the other by a mile in head-to-head trial

New Delhi: A head-to-head clinical trial comparing two globally popular obesity drugs—tirzepatide and semaglutide—revealed that the…

Obesity medicine: Scientists developing cream to reduce weight, says report | Mint

Obesity medicine: In a significant breakthrough, scientists are developing a cream to reduce body weight, DailyMail.com…

Big buzz over Mounjaro launch but here’s why India’s anti-obesity drug market may only take off next yr

The company has introduced the drug in two strengths—2.5 mg vials priced at Rs 3,500 and…

Eli Lilly launches its blockbuster weight loss drug Mounjaro in India | Company Business News

Mumbai: US drugmaker Eli Lilly & Co. brought its anti-obesity drug Mounjaro to India on Thursday,…

Mounjaro hits shelves in India: How Eli Lilly’s anti-diabetes drug compares with Ozempic — price, side effects and more | Mint

Eli Lilly has introduced Mounjaro (tirzepatide), a weekly injectable medication for obesity and type 2 diabetes,…

The economics of thinness (Ozempic edition)

As some describe it, this is where the world is now heading owing to the discovery…